O'Shaughnessy Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,784
| Closed | -$242K | – | 1915 |
|
|
2021
Q3 | $242K | Sell |
2,784
-3,194
| -53% | -$278K | ﹤0.01% | 950 |
|
|
2021
Q2 | $489K | Buy |
5,978
+400
| +7% | +$32.7K | 0.01% | 668 |
|
|
2021
Q1 | $530K | Sell |
5,578
-645
| -10% | -$61.3K | 0.01% | 587 |
|
|
2020
Q4 | $386K | Buy |
6,223
+5,886
| +1,747% | +$365K | 0.01% | 594 |
|
|
2020
Q3 | $20K | Sell |
337
-1,356
| -80% | -$80.5K | ﹤0.01% | 1248 |
|
|
2020
Q2 | $118K | Sell |
1,693
-4,123
| -71% | -$287K | ﹤0.01% | 799 |
|
|
2020
Q1 | $264K | Sell |
5,816
-1,309
| -18% | -$59.4K | 0.01% | 401 |
|
|
2019
Q4 | $464K | Sell |
7,125
-436
| -6% | -$28.4K | 0.01% | 418 |
|
|
2019
Q3 | $470K | Buy |
7,561
+4,062
| +116% | +$252K | 0.01% | 383 |
|
|
2019
Q2 | $249K | Sell |
3,499
-4,040
| -54% | -$287K | 0.01% | 504 |
|
|
2019
Q1 | $588K | Sell |
7,539
-13,643
| -64% | -$1.06M | 0.01% | 342 |
|
|
2018
Q4 | $1.8M | Sell |
21,182
-1,723
| -8% | -$146K | 0.05% | 196 |
|
|
2018
Q3 | $3.89M | Buy |
22,905
+9,113
| +66% | +$1.55M | 0.08% | 142 |
|
|
2018
Q2 | $1.77M | Buy |
13,792
+5,615
| +69% | +$721K | 0.04% | 200 |
|
|
2018
Q1 | $843K | Buy |
8,177
+1,600
| +24% | +$165K | 0.02% | 269 |
|
|
2017
Q4 | $562K | Buy |
6,577
+2,853
| +77% | +$244K | 0.01% | 363 |
|
|
2017
Q3 | $316K | Buy |
+3,724
| New | +$316K | 0.01% | 437 |
|
|
2014
Q3 | – | Sell |
-138
| Closed | -$5K | – | 1023 |
|
|
2014
Q2 | $5K | Hold |
138
| – | – | ﹤0.01% | 847 |
|
|
2014
Q1 | $6K | Hold |
138
| – | – | ﹤0.01% | 813 |
|
|
2013
Q4 | $5K | Sell |
138
-131
| -49% | -$4.75K | ﹤0.01% | 832 |
|
|
2013
Q3 | $7K | Buy |
+269
| New | +$7K | ﹤0.01% | 782 |
|